WWT, A., MR, S., KL, H., L, L., S, G., DJ, M., . . . TR, M. (2024). Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 16(2), e12601. https://doi.org/10.1002/dad2.12601
Chicago Style (17th ed.) CitationWWT, Aye, et al. "Early-phase Amyloid PET Reproduces Metabolic Signatures of Cognitive Decline in Parkinson's Disease." Alzheimer's & Dementia (Amsterdam, Netherlands) 16, no. 2 (2024): e12601. https://doi.org/10.1002/dad2.12601.
MLA (9th ed.) CitationWWT, Aye, et al. "Early-phase Amyloid PET Reproduces Metabolic Signatures of Cognitive Decline in Parkinson's Disease." Alzheimer's & Dementia (Amsterdam, Netherlands), vol. 16, no. 2, 2024, p. e12601, https://doi.org/10.1002/dad2.12601.